4.7 Article

Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies

Related references

Note: Only part of the references are listed.
Review Microbiology

Latency and lytic replication in Epstein-Barr virus-associated oncogenesis

Christian Muenz

NATURE REVIEWS MICROBIOLOGY (2019)

Review Oncology

The Global Landscape of EBV-Associated Tumors

Claire Shannon-Lowe et al.

FRONTIERS IN ONCOLOGY (2019)

Article Medicine, Research & Experimental

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes

Alena Gros et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Medicine, Research & Experimental

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model

Benjamin Y. Jin et al.

JCI INSIGHT (2018)

Review Cell Biology

Immunotherapy against cancer-related viruses

Haruko Tashiro et al.

CELL RESEARCH (2017)

Review Oncology

Epstein-Barr virus: more than 50 years old and still providing surprises

Lawrence S. Young et al.

NATURE REVIEWS CANCER (2016)

Article Biotechnology & Applied Microbiology

Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

Ulrike Gerdemann et al.

MOLECULAR THERAPY (2012)